Felix Scheuplein

Senior Director, Biology Drug Discovery at Blueprint Medicines
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Greater Boston
Languages
  • German Native or bilingual proficiency
  • English Full professional proficiency
Skills

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now

Experience

  • Blueprint Medicines
    • United States
    • Biotechnology Research
    • 400 - 500 Employee
    • Senior Director, Biology Drug Discovery
      • Jun 2023 - Present

    • Director, Biology Drug Discovery
      • Nov 2018 - Jun 2023

    • Principal Scientist, Immunology
      • Feb 2018 - Nov 2018

      Biology Team Lead for 2 undisclosed small molecule Immuno-Oncology programs. Collaboration co-coordinator.

    • Senior Scientist II, Immunology
      • Jan 2016 - Feb 2018

      Biology Team Lead - undisclosed small molecule Immuno-Oncology Program. Biology Team Lead Phenotypic Screening.

  • NKT Therapeutics Inc.
    • Senior Laboratory Head Preclinical Research
      • Jun 2012 - Dec 2015

      Preclinical Development of Immunomodulatory Monoclonal Antibodies and Support of Phase 1 Clinical Trial

    • Senior Scientist
      • Sep 2009 - Jun 2012

      Preclinical development of human iNKT cell specific mAbs

  • The Jackson Laboratory
    • United States
    • Biotechnology Research
    • 700 & Above Employee
    • Postdoctoral Fellow
      • Apr 2006 - Aug 2009

      Investigating the role of iNKT cells in T1D. Testing pharmacologic intervention of iNKT cell apoptosis in the NOD mouse using a novel llama single chain VHH approach. Investigating the role of iNKT cells in T1D. Testing pharmacologic intervention of iNKT cell apoptosis in the NOD mouse using a novel llama single chain VHH approach.

  • University Heart and Vascular Center Hamburg
    • Germany
    • Hospitals and Health Care
    • 1 - 100 Employee
    • PhD Thesis
      • Apr 2002 - Mar 2006

      ART2 mediated ADP-Ribosylation of P2X7 purino-receptor in murine T cells and its downstream consequences ART2 mediated ADP-Ribosylation of P2X7 purino-receptor in murine T cells and its downstream consequences

  • University Heart and Vascular Center Hamburg
    • Germany
    • Hospitals and Health Care
    • 1 - 100 Employee
    • Diploma Thesis, Genetics
      • Mar 2001 - Dec 2001

      Molecular-genetic Analysis of the Ryanodine Receptor (RYR1) Gene in Malignant Hyperthermia susceptible (MHS) patients Molecular-genetic Analysis of the Ryanodine Receptor (RYR1) Gene in Malignant Hyperthermia susceptible (MHS) patients

Education

  • University of Hamburg
    PhD, Immunology
    2002 - 2006
  • University of Hamburg
    Dipl. Biol., Genetics, Microbiology, Informatics
    1995 - 2002
  • JAX annual short course mouse models in cancer research
  • Massbio - Project management class

Community

You need to have a working account to view this content. Click here to join now